(Q45006199)

8 December 2017

title

Use of single-dose rasburicase in an obese female (English)

1 reference

8 December 2017

0 references

Carl B Shanholtz

4

0 references

author name string

Tamra M Arnold

series ordinal

1

1 reference

8 December 2017

Jameson P Reuter

series ordinal

2

1 reference

8 December 2017

Bryna S Delman

series ordinal

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

3 August 2004

1 reference

Annals of Pharmacotherapy

8 December 2017

published in

1 reference

8 December 2017

volume

38

1 reference

8 December 2017

issue

9

1 reference

8 December 2017

page(s)

1428-1431

1 reference

Acute tumor lysis syndrome

8 December 2017

cites work

1 reference

Management of acute tumor lysis syndrome

21 January 2018

1 reference

Rasburicase: a potent uricolytic agent

21 January 2018

1 reference

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

21 January 2018

1 reference

Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study

21 January 2018

1 reference

Development of a two-site immunoassay of recombinant urate oxidase (SR 29142) and its use for determination of pharmacokinetic parameters in rats and baboons.

21 January 2018

1 reference

Advances in the management of malignancy-associated hyperuricaemia

21 January 2018

1 reference

Treatment of impending tumor lysis with single-dose rasburicase.

21 January 2018

1 reference

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E002

1 reference

8 December 2017

1 reference